Manufacturer: Novartis

Tasigna is used to treat a type of leukemia called Philadelphia chromosome positive chronic myeloid leukemia (Ph-positive CML). CML is a blood cancer that causes the body to produce an excess of abnormal white blood cells.

Tasigna is used in adults and children with newly diagnosed CML. It is also used in children with CML who no longer benefit from previous treatment, including imatinib, or who have had serious side effects from previous treatment and cannot continue to use it.